Superior vena cava echocardiography as a screening tool to predict cardiovascular implantable electronic device lead fibrosis
- PMID: 25883753
- PMCID: PMC4398781
- DOI: 10.4250/jcu.2015.23.1.27
Superior vena cava echocardiography as a screening tool to predict cardiovascular implantable electronic device lead fibrosis
Abstract
Background: Currently there is no noninvasive imaging modality used to risk stratify patients requiring lead extractions. We report the novel use of superior vena cava (SVC) echocardiography to identify lead fibrosis and complex cardiac implantable electronic device (CIED) lead extraction. With an aging population and expanding indications for cardiac device implantation, the ability to deal with the complications associated with chronically implanted device has also increased.
Methods: This was a retrospective analysis of Doppler echocardiography recorded in our outpatient Electrophysiology/Device Clinic office over 6 months. Images from 109 consecutive patients were reviewed.
Results: 62% (68/109) did not have a CIED and 38% (41/109) had a CIED. In patients without a CIED, 6% (4/68) displayed turbulent color flow by Doppler in the SVC, while 22% (9/41) of patients with a CIED displayed turbulent flow. Fisher's exact test found a statistically significant difference between the two groups (p value < 0.05). The CIED group was subdivided into 2 groups based on device implant duration (< 2 years vs. ≥ 2 years). Of the CIED implanted for ≥ 2 years, 27% (9/33) had turbulent flow in the SVC by Doppler, while no patients (0/8) with implant durations < 2 years demonstrated turbulent flow. Nine patients underwent subsequent lead extraction. A turbulent color pattern successfully identified all 3 patients that had significant fibrosis in the SVC found during extraction.
Conclusion: Our data suggests that assessing turbulent flow using color Doppler in the SVC may be a valuable noninvasive screening tool prior to lead extraction in predicting complex procedures.
Keywords: Cardiac implantable electronic device; Echocardiography; Lead extraction.
Figures
Similar articles
-
Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices.Heart Rhythm. 2021 Mar;18(3):392-398. doi: 10.1016/j.hrthm.2020.11.012. Epub 2020 Nov 17. Heart Rhythm. 2021. PMID: 33212249
-
Cardiac resynchronization therapy in a patient with persistent left superior vena cava draining into the coronary sinus and absent innominate vein: a case report and review of literature.Indian Pacing Electrophysiol J. 2014 Oct 6;14(5):268-72. doi: 10.1016/s0972-6292(16)30799-9. eCollection 2014 Sep. Indian Pacing Electrophysiol J. 2014. PMID: 25408568 Free PMC article.
-
The prevalence of superior vena cava anomalies as detected in cardiac implantable electronic device recipients at a tertiary cardiology centre over a 12-year period.Hellenic J Cardiol. 2016 Mar-Apr;57(2):101-6. doi: 10.1016/j.hjc.2016.03.003. Epub 2016 Apr 5. Hellenic J Cardiol. 2016. PMID: 27445024
-
Superior vena cava obstruction and cardiovascular implantable electronic devices-a new era of leadless devices.Mediastinum. 2023 Dec 12;8:1. doi: 10.21037/med-23-33. eCollection 2024. Mediastinum. 2023. PMID: 38322191 Free PMC article. Review.
-
Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.JACC Cardiovasc Imaging. 2019 Apr;12(4):622-636. doi: 10.1016/j.jcmg.2018.09.028. JACC Cardiovasc Imaging. 2019. PMID: 30947905 Review.
Cited by
-
The prognostic value of transesophageal echocardiography after transvenous lead extraction: landscape after battle.Cardiovasc Diagn Ther. 2021 Apr;11(2):394-410. doi: 10.21037/cdt-20-871. Cardiovasc Diagn Ther. 2021. PMID: 33968618 Free PMC article.
-
Three simple but interesting transthoracic echocardiographic road maps for proximal superior vena cava visualisation in healthy young adults.Int J Cardiol Heart Vasc. 2022 Mar 18;39:101004. doi: 10.1016/j.ijcha.2022.101004. eCollection 2022 Apr. Int J Cardiol Heart Vasc. 2022. PMID: 35321114 Free PMC article.
-
Transvenous Lead Extractions: Current Approaches and Future Trends.Arrhythm Electrophysiol Rev. 2018 Aug;7(3):210-217. doi: 10.15420/aer.2018.33.2. Arrhythm Electrophysiol Rev. 2018. PMID: 30416735 Free PMC article. Review.
-
Prognostic Value of Preoperative Echocardiographic Findings in Patients Undergoing Transvenous Lead Extraction.Int J Environ Res Public Health. 2021 Feb 14;18(4):1862. doi: 10.3390/ijerph18041862. Int J Environ Res Public Health. 2021. PMID: 33672931 Free PMC article.
-
Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction.Cells. 2021 Jul 15;10(7):1794. doi: 10.3390/cells10071794. Cells. 2021. PMID: 34359963 Free PMC article. Review.
References
-
- Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33:705–711. - PubMed
-
- Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH, 3rd, Epstein LM, Friedman RA, Kennergren CE, Mitkowski P, Schaerf RH, Wazni OM Heart Rhythm Society; American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA) Heart Rhythm. 2009;6:1085–1104. - PubMed
-
- Love CJ, Wilkoff BL, Byrd CL, Belott PH, Brinker JA, Fearnot NE, Friedman RA, Furman S, Goode LB, Hayes DL, Kawanishi DT, Parsonnet V, Reiser C, Van Zandt HJ. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol. 2000;23(4 Pt 1):544–551. - PubMed
-
- Kutalek SP. Pacemaker and defibrillator lead extraction. Curr Opin Cardiol. 2004;19:19–22. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources